Activation of Mononuclear Cells by Interleukin-12: An In Vivo Study in Chimpanzees
- 1 July 1999
- journal article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 19 (4) , 231-238
Abstract
Interleukin (IL)-12 is considered a central regulator of host resistance against a variety of pathogens. Therefore, IL-12 has been advocated as a potential therapeutic agent in infections. To...Keywords
This publication has 50 references indexed in Scilit:
- Interleukin‐12 Induces Sustained Activation of Multiple Host Inflammatory Mediator Systems in ChimpanzeesThe Journal of Infectious Diseases, 1999
- Characterization of a novel subset of CD8(+) T cells that expands in patients receiving interleukin-12.Journal of Clinical Investigation, 1998
- The expanding universe of T-cell subsets: Th1, Th2 and moreImmunology Today, 1996
- Unlocking the secrets of CTL and NK cellsImmunology Today, 1995
- Granzymes: exogenous porteinases that induce target cell apoptosisImmunology Today, 1995
- Multiple Effects on Peripheral Hematology Following Administration of Recombinant Human Interleukin 12 to Nonhuman PrimatesBiochemical and Biophysical Research Communications, 1994
- Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells.Journal of Experimental Medicine, 1994
- Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.Journal of Clinical Investigation, 1994
- The role of natural killer cells in innate resistance to infectionCurrent Opinion in Immunology, 1993
- Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cellsCellular Immunology, 1991